Peter Capell

613 total citations
8 papers, 454 citations indexed

About

Peter Capell is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Reproductive Medicine. According to data from OpenAlex, Peter Capell has authored 8 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Reproductive Medicine. Recurrent topics in Peter Capell's work include Thyroid Cancer Diagnosis and Treatment (3 papers), Hormonal and reproductive studies (2 papers) and Ovarian function and disorders (2 papers). Peter Capell is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (3 papers), Hormonal and reproductive studies (2 papers) and Ovarian function and disorders (2 papers). Peter Capell collaborates with scholars based in United States. Peter Capell's co-authors include Bernardo Goulart, Keith D. Eaton, Renato Martins, David A. Mankoff, Julie E. Bauman, Laurie L. Carr, C. Alvin Paulsen, Stephen R. Plymate, David Mankoff and R. Alan Failor and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Peter Capell

8 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Capell United States 5 385 167 97 63 50 8 454
C. Passler Austria 7 279 0.7× 68 0.4× 82 0.8× 57 0.9× 22 0.4× 12 379
Danuta Gąsior‐Perczak Poland 13 333 0.9× 103 0.6× 139 1.4× 101 1.6× 26 0.5× 37 462
Stefania Marchisotta Italy 9 435 1.1× 99 0.6× 173 1.8× 86 1.4× 26 0.5× 11 521
Barbara Puligheddu Italy 8 248 0.6× 115 0.7× 33 0.3× 107 1.7× 23 0.5× 13 436
Stephanie Allelein Germany 11 286 0.7× 109 0.7× 47 0.5× 49 0.8× 34 0.7× 26 363
F. J. Seif Germany 10 271 0.7× 64 0.4× 62 0.6× 110 1.7× 25 0.5× 29 395
Jean Leyland United Kingdom 9 185 0.5× 96 0.6× 87 0.9× 111 1.8× 32 0.6× 9 328
Joana Simões‐Pereira Portugal 10 162 0.4× 59 0.4× 39 0.4× 57 0.9× 29 0.6× 38 270
Ferenc Juhász Hungary 10 192 0.5× 88 0.5× 74 0.8× 90 1.4× 9 0.2× 21 350
Lina Inagaki Japan 7 203 0.5× 165 1.0× 45 0.5× 54 0.9× 87 1.7× 14 327

Countries citing papers authored by Peter Capell

Since Specialization
Citations

This map shows the geographic impact of Peter Capell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Capell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Capell more than expected).

Fields of papers citing papers by Peter Capell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Capell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Capell. The network helps show where Peter Capell may publish in the future.

Co-authorship network of co-authors of Peter Capell

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Capell. A scholar is included among the top collaborators of Peter Capell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Capell. Peter Capell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Carr, Laurie L., David A. Mankoff, Bernardo Goulart, et al.. (2010). Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation. Clinical Cancer Research. 16(21). 5260–5268. 324 indexed citations
2.
Goulart, Bernardo, et al.. (2009). Phase II trial of continuous dosing of sunitinib in advanced, FDG-PET avid, medullary thyroid carcinoma (MTC) and well-differentiated thyroid cancer (WDTC). Journal of Clinical Oncology. 27(15_suppl). 6056–6056. 18 indexed citations
3.
Goulart, Bernardo, et al.. (2008). Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC). Journal of Clinical Oncology. 26(15_suppl). 6062–6062. 28 indexed citations
4.
Capell, Peter. (2004). Case Study: Hemachromatosis in Type 2 Diabetes. Clinical Diabetes. 22(2). 101–102. 4 indexed citations
5.
Failor, R. Alan & Peter Capell. (2003). Hyperaldosteronism and pheochromocytoma: new tricks and tests. Primary Care Clinics in Office Practice. 30(4). 801–820. 3 indexed citations
6.
Capell, Peter, et al.. (1976). Ambulatory Care Manual for Nurse Practitioners. The Nurse Practitioner. 2(1). 38–38. 4 indexed citations
7.
Capell, Peter, et al.. (1973). The Effect of Short-Term Testosterone Administration on Serum FSH, LH and Testosterone Levels: Evidence for Selective Abnormality in LH Control in Patients with Klinefelter's Syndrome. The Journal of Clinical Endocrinology & Metabolism. 37(5). 752–759. 58 indexed citations
8.
Capell, Peter & C. Alvin Paulsen. (1972). The effect of exogenous testosterone upon serum FSH and LH concentrations in normal males. Contraception. 6(2). 135–143. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026